Viewing Study NCT02283658


Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-04-12 @ 9:03 PM
Study NCT ID: NCT02283658
Status: COMPLETED
Last Update Posted: 2020-10-23
First Post: 2014-11-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Sponsor: Mayo Clinic
Organization: